HEALTHPEAK PROPERTIES, INC.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Net Income From Continuing Operations $516.4m $334.8m $267.3m $101.0m
Net Income (Loss) Attributable to Parent $627.7m $414.2m $1.1b $45.5m $413.6m $505.5m $500.4m $306.0m $243.1m $71.3m
Net Income (Loss) Available to Common Stockholders, Basic $626.5m $413.0m $1.1b $44.0m $411.1m $502.3m $497.8m $304.3m $242.4m $70.5m
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest $639.9m $422.6m $1.1b $60.1m $428.3m $525.9m $516.4m $334.8m $267.3m $101.0m
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent $362.0m $414.2m $1.1b $45.5m $146.1m $119.9m $497.6m $306.0m $243.1m $71.3m
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $374.2m $422.6m $1.1b $60.1m $160.5m $137.7m $513.5m $334.8m $267.3m $101.0m
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $265.8m $0 $0 $267.7m $388.2m $2.9m $0 $0
Net Income (Loss) Attributable to Noncontrolling Interest $12.2m $8.5m $12.4m $14.5m
Depreciation and amortization $568.1m $534.7m $549.5m $660.0m $697.1m $684.3m $710.6m $749.9m $1.1b $1.1b
Amortization of Debt Issuance Costs and Discounts $20.0m $14.6m $12.6m $10.9m $10.2m $9.2m $10.9m $11.9m $29.0m $31.9m
Amortization Cash Flow ($25.8m) ($30.8m) ($36.7m)
Amortization Of Intangibles ($25.8m) ($30.8m) ($36.7m)
Depreciation Amortization Depletion $710.6m $724.1m $1.0b $1.0b
Deferred Income Tax Expense (Benefit) ($13.7m) ($5.5m) ($21.4m) ($18.3m) ($1.7m) ($4.4m) ($5.7m) ($14.6m) ($1.7m) $3.8m
Deferred Income Tax ($6.0m) ($14.6m) ($1.7m) $3.8m
Deferred Tax ($6.0m) ($14.6m) ($1.7m) $3.8m
Share-based Payment Arrangement, Noncash Expense $22.9m $14.3m $16.6m $18.2m $17.4m $18.2m $26.5m $14.5m $15.5m $14.4m
Share-based Payment Arrangement, Expense $23.0m $14.0m $15.0m $18.0m $21.0m $23.0m $32.0m $19.0m $20.0m $20.0m
Equity Method Investment, Other than Temporary Impairment $6.0m
Goodwill, Impairment Loss $0 $0 $0 $0 $0 $0 $0
Marketable Securities, Gain (Loss), Excluding Other-than-temporary Impairment Loss $50.9m $0 $0
Share-based Payment Arrangement, Expensed and Capitalized, Amount $14.0m $20.0m $26.0m $26.0m $29.0m $28.0m
Asset Impairment Charge $7.0m ($5.6m) $23.0m ($893k)
Income (Loss) from Equity Method Investments $11.4m $10.9m ($2.6m) ($8.6m) ($66.6m) $6.1m $2.0m $10.2m ($1.5m) ($174.0m)
Gain (Loss) on Extinguishment of Debt ($46.0m) ($54.2m) ($44.2m) ($58.4m) ($42.9m) ($225.8m) $0 $0
Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal $6.5m $2.1m $7.7m $3.1m
Income Tax Expense (Benefit) $4.5m ($1.3m) ($17.9m) ($17.3m) ($9.4m) ($3.3m) ($4.4m) ($9.6m) $4.3m $9.3m
Operating Lease, Lease Income $1.2b $1.2b $1.4b $1.5b $1.6b $2.1b $2.2b
Other Nonoperating Income (Expense) $3.7m $31.4m $13.3m $182.1m $234.7m $6.3m $326.3m $6.8m $59.3m $479k
Earnings (Loss)es From Equity Investments ($2.0m) ($10.2m) $1.5m $174.0m
Changes in operating assets and liabilities:
Additional Financial Items
Increase (Decrease) in Accounts Receivable ($3.8m)
Deconsolidation, Gain (Loss), Amount $311.0m $78.0m
Foreign Currency Transaction Gain (Loss), before Tax ($188k)
General and Administrative Expense $103.6m $88.8m $96.7m $93.0m $93.2m $98.3m $131.0m $95.1m $97.2m $90.4m
Goodwill $42.4m $47.0m $47.0m $47.0m $18.0m $18.0m $18.0m $18.0m $68.5m $68.5m
Insured Event, Gain (Loss) ($12.1m) $0 $3.7m ($469k) ($1.6m) ($7.2m) $3.1m ($29.1m) ($621k)
Noncash Merger Related Costs $16.2m $0
Nonoperating Income (Expense) $122.3m $333.8m $895.1m $146.7m $282.1m ($29.0m) $335.3m $93.3m $238.0m $70.0m
Operating Costs and Expenses $1.1b
Operating Expenses $738.4m $666.3m $705.0m $879.4m $782.5m $773.3m $863.0m $902.1m
Provision for Loan, Lease, and Other Losses $8.9m
Financing Receivable, Credit Loss, Expense (Reversal) $1.7m
Beginning Cash Position $219.4m $126.8m $169.0m $184.3m
Cash Flow From Continuing Financing Activities ($116.5m) ($337.3m) ($941.4m) $136.1m
Cash Flow From Continuing Investing Activities ($876.3m) ($576.8m) ($113.8m) ($1.0b)
Change In Account Payable $136.3m ($40.7m) ($28.6m) ($25.3m)
Change In Other Working Capital $145.2m $114.3m $147.3m
Change In Payable $136.3m ($40.7m) ($28.6m) ($25.3m)
Change In Payables And Accrued Expense $136.3m ($40.7m) ($28.6m) ($25.3m)
Change In Receivables ($17.4m) ($21.6m) ($40.9m) ($16.3m)
Change In Working Capital $118.9m $82.9m $44.8m $105.7m
Changes In Account Receivables ($17.4m) ($21.6m) ($40.9m) ($16.3m)
Changes In Cash ($92.6m) $42.2m $15.3m $353.4m
End Cash Position $126.8m $169.0m $184.3m $537.7m
Financing Cash Flow ($116.5m) ($337.3m) ($941.4m) $136.1m
Free Cash Flow $900.3m $956.2m $1.1b $1.3b
Gain Loss On Investment Securities ($33.1m) ($86.5m) ($178.7m) ($69.5m)
Gain Loss On Sale Of Business ($311.4m) ($234k) ($77.5m) $0
Investing Cash Flow ($876.3m) ($576.8m) ($113.8m) ($1.0b)
Issuance Of Capital Stock $308.1m $278k $317k $1.1m
Net Business Purchase And Sale $104.8m ($88.4m) ($115.2m) ($86.8m)
Operating Gains Losses ($346.6m) ($96.9m) ($254.7m) $104.5m
Other Non Cash Items ($127.4m) ($83.9m) ($78.4m) ($115.9m)
Purchase Of Business ($21.1m) ($88.4m) ($240.8m) ($86.8m)
Repurchase Of Capital Stock ($67.8m) ($6.5m) ($190.7m) ($97.1m)
Sale Of Business $126.0m $0 $125.7m $0
Stock Based Compensation $26.5m $14.5m $31.8m $14.4m
Discontinued Operation, Income (Loss) from Discontinued Operation During Phase-out Period, Net of Tax $400.7m $0 $0
Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, Net of Tax ($707k) ($799k) ($18.1m) ($1.0m)
Net Cash Provided by (Used in) Operating Activities $1.2b $847.0m $848.7m $846.1m $758.4m $795.2m $900.3m $956.2m $1.1b $1.3b
Cash flows from investing activities:
Payments to Acquire Property, Plant, and Equipment $458.9m $471.8m $607.2m $744.0m $788.9m $759.7m $962.0m $774.6m $736.8m $894.9m
Net Investment Properties Purchase And Sale ($991.9m) ($605.4m) $44.3m ($912.6m)
Net Investment Purchase And Sale $0 $0
Purchase Of Investment $0 $0
Purchase Of Investment Properties ($1.0b) ($747.1m) ($604.3m) ($1.3b)
Gain (Loss) on Sale of Investments $164.7m $356.6m $926.0m $22.9m $550.5m $605.3m $10.4m $86.5m $178.7m $69.5m
Gains (Losses) on Sales of Investment Real Estate $164.7m $356.6m $926.0m $22.9m $90.3m $190.6m $9.1m $86.5m $178.7m $69.5m
Sale Of Investment Properties $47.9m $141.7m $648.5m $337.7m
Net Other Investing Changes ($1.8m) $96.4m ($65.8m) ($63.8m)
Net Cash Provided by (Used in) Investing Activities ($410.6m) $1.2b $1.8b ($1.4b) ($1.0b) $531.0m ($876.3m) ($576.8m) ($113.8m) ($1.0b)
Cash flows from financing activities:
Issuance Of Debt $16.4b $11.1b $4.5b $13.1b
Long Term Debt Issuance $16.4b $11.1b $4.5b $13.1b
Net Issuance Payments Of Debt $324.6m $378.1m $153.2m $1.1b
Net Long Term Debt Issuance $324.6m $378.1m $153.2m $1.1b
Net Short Term Debt Issuance $1.0b ($170.4m) ($275.6m)
Short Term Debt Issuance $16.8b $15.9b $10.3b
Long Term Debt Payments ($16.1b) ($10.7b) ($4.3b) ($12.0b)
Repayment Of Debt ($16.1b) ($10.7b) ($4.3b) ($12.0b)
Short Term Debt Payments ($15.8b) ($16.1b) ($10.6b)
Common Stock Issuance $308.1m $278k $317k $1.1m
Net Common Stock Issuance $240.3m ($6.2m) ($190.4m) ($96.0m)
Payments for Repurchase of Common Stock $8.7m $4.8m $3.4m $5.0m $10.5m $12.8m $67.8m $6.5m $190.7m $97.1m
Common Stock Payments ($67.8m) ($6.5m) ($190.7m) ($97.1m)
Proceeds from Noncontrolling Interests $1.6m $299.7m $33.3m $0 $640k $1.4m $489k $12k $13.1m
Proceeds from (Payments to) Noncontrolling Interests $11.8m
Dividends paid $979.5m $695.0m $696.9m $720.1m $787.1m $650.1m $648.0m $657.0m $794.8m $849.1m
Cash Dividends Paid ($648.0m) ($657.0m) ($794.8m) ($849.1m)
Common Stock Dividend Paid ($648.0m) ($657.0m) ($794.8m) ($849.1m)
Dividend Received CFO $943k $910k $12.0m $17.1m
Dividends Received CFI $12.5m $20.6m $22.9m $28.5m
Net Other Financing Charges ($33.3m) ($52.1m) ($109.5m) ($27.5m)
Net Cash Provided by (Used in) Financing Activities ($1.1b) ($2.1b) ($2.6b) $647.3m $246.4m ($1.3b) ($116.5m) ($337.3m) ($941.4m) $136.1m
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $245k ($153k) $0 $0
Effect Of Exchange Rate Changes $0 $0
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect ($54.8m) $57.6m $44.8m ($3.0m) $37.8m ($92.6m) $42.2m $15.3m $353.4m
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $82.2m $139.8m $184.7m $111.4m $211.7m $126.8m $169.0m $184.3m
Supplemental disclosure of cash flow information:
Change In Cash Supplemental As Reported ($92.6m) $42.2m $15.3m $353.4m
Interest Paid, Excluding Capitalized Interest, Operating Activities $489.5m $309.1m $275.7m $201.8m $209.8m $173.0m $162.1m $188.2m $249.5m $260.1m
Income Taxes Paid, Net $13.7m $10.0m $4.5m $1.4m ($786k) $4.5m ($1.9m) $1.9m $7.9m $3.4m

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.